A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

Surgical resection of head and neck squamous-cell carcinoma (HNSCC) is associated with high rates of local and distant recurrence, partially mitigated by adjuvant therapy. A pre-existing immune response in the patient’s tumor is associated with better outcomes following treatment with conventional t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Sharon, Shay, Baird, Jason R., Bambina, Shelly, Kramer, Gwen, Blair, Tiffany C., Jensen, Shawn M., Leidner, Rom S., Bell, R. Bryan, Casap, Nardy, Crittenden, Marka R., Gough, Michael J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238246/
https://ncbi.nlm.nih.gov/pubmed/34194619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27982
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares